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COMPARISON OF RESULTS Deaths The number of deaths was the same in treated and untreated groups (Table II) . In series 1 there was one death in a treated patient and one in a control, and in series 2 there were four deaths among treated patients and four among controls. On clinical grounds the deaths could be subdivided into two groups.
1. Death from Delayed Shock (Cases 5, 7, 10), when hypotensive shock supervened after admission to the trial. Extension or recurrence of infarction seemed the likely explanation and two of the patients had severe retrosternal pain during the terminal episode.
2. Sudden Death (Cases 1, 2, 3, 4, 6, 8, 9) , presumed due to ventricular fibrillation. There were four deaths in this category among the treated group and three among the controls. 
Abnormal Rhythms
In tabulating the incidence of abnormal rhythms (Table III) , the results in series 1 and 2 have been combined. Only the arrhythmias recorded in the routine weekly cardiographs have been 
DISCUSSION
Although there has been no previously recorded trial of procaine amide, quinidine has been given prophylactically to patients with myocardial infarction with the object of preventing ventricular fibrillation. Boone and Pappas (1956) were impressed with the results, but Cutts and Rapoport (1952) found that deaths from ventricular fibrillation were not reduced. There has, however,
